Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Devoogdt, Nick" or (type any "bookEditor journalEditor issueEditor" and editor="Devoogdt,...

Add to list
- Journal Article
- A1
- open access
Current status and future expectations of nanobodies in oncology trials

Tessa De Pauw, Lynn De Mey, Jens Debacker (UGent) , Geert Raes, Jo Van Ginderachter (UGent) , Timo De Groof and Nick Devoogdt

(2023) EXPERT OPINION ON INVESTIGATIONAL DRUGS.
Add to list
- Conference Paper
- C3
Safety assessment of fluorescence-labeled anti-EGFR nanobody in healthy dogs

Nayra Cristina Herreira do Valle (UGent) , Simone Janssen (UGent) , Marcus Stroet, Sofie Pollenus, Sonja Van den Block, Nick Devoogdt, Jens Debacker (UGent) , Sophie Hernot and Hilde De Rooster (UGent)

(2023) EMIM 2023, European Molecular Imaging Meeting, Abstracts.
Add to list
- Journal Article
- A1
- open access
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs

Nayra Cristina Herreira do Valle (UGent) , Simone Janssen (UGent) , Marcus C. M. Stroet, Sofie Pollenus, Sonja Van den Block, Nick Devoogdt, Jens Debacker (UGent) , Sophie Hernot and Hilde De Rooster (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Conference Paper
- C3
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients

Odrade Gondry, Catarina Xavier, Johannes Heemskerk, Laurens Albert J Raes, Jens Debacker (UGent) , Frank De Geeter, Christel Fontaine, Marian Vanhoeij, SANDRINE ASPESLAGH (UGent) , Sofie Joris, et al.

(2023) EMIM 2023, European Molecular Imaging Meeting, Abstracts.
Add to list
- Journal Article
- A1
- open access
CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens (UGent) , Serge Muyldermans, et al.

(2021) ONCOIMMUNOLOGY. 10(1).
Add to list
- Journal Article
- A1
- open access
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.

(2021) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 22. p.172-182
Add to list
- Journal Article
- A1
- open access
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Bert Schepens (UGent) , Loes van Schie (UGent) , Wim Nerinckx (UGent) , Kenny Roose (UGent) , Wander Van Breedam (UGent) , Daria Fijalkowska (UGent) , Simon Devos (UGent) , Wannes Weyts (UGent) , Sieglinde De Cae (UGent) , Sandrine Vanmarcke (UGent) , et al.

(2021) SCIENCE TRANSLATIONAL MEDICINE. 13(621).
Add to list
- Journal Article
- A1
- open access
Improved detection of molecular markers of atherosclerotic plaques using sub-millimeter PET imaging

Jessica Bridoux, Sara Neyt (UGent) , Pieterjan Debie, Benedicte Descamps (UGent) , Nick Devoogdt, Frederik Cleeren, Guy Bormans, Alexis Broisat, Vicky Caveliers, Catarina Xavier, et al.

(2020) MOLECULES. 25(8).
Add to list
- Journal Article
- A1
- open access
Anti-human PD-L1 Nanobody for immuno-PET imaging : validation of a conjugation strategy for clinical translation

Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, Geert Raes, Sara Neyt (UGent) , Christian Vanhove (UGent) , Karine Breckpot, et al.

(2020) BIOMOLECULES. 10(10).
Add to list
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

Evangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, Danielle Berus, Geert Stange, Emile J Clappaert, Sana Arnouk, Ana Rita Pombo Antunes, Ahmet Krasniqi, Tony Lahoutte, et al.

(2019) JOURNAL OF CONTROLLED RELEASE. 314. p.1-11

Academic Bibliography

Current status and future expectations of nanobodies in oncology trials

Safety assessment of fluorescence-labeled anti-EGFR nanobody in healthy dogs

Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs

A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients

CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Improved detection of molecular markers of atherosclerotic plaques using sub-millimeter PET imaging

Anti-human PD-L1 Nanobody for immuno-PET imaging : validation of a conjugation strategy for clinical translation

Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

Contents

Support

Contact